Welcome to the Q-Core
Qurasense is developing a 100% non-invasive blood analysis platform for women: health-tracking menstrual pads! Our Q-pads collect and analyze data rich menstrual blood to give you critical health insights. But of course you know that already since you've already crossed paths with either Adrianna, Sara, or Søren somewhere along the Q-journey.
The Q-core is a community of amazing women hand-picked to work with us on optimizing the product. You were selected based on your enthusiasm and responsiveness. It is critical that we can rely on your strict adherence to instructions we provide as part of your participation in our studies.
We are exceptionally grateful to our Q-core, and we will show our gratitude on an ongoing basis. You will be invited to all Qurasense launch events and parties. We will be sure to recognize you for your service to our cause at these events as your data is what makes our work possible. Together, we can build a future in which no woman needs to suffer from treatable conditions. And certainly, we will make sure your bathroom cabinets are stuffed full of complimentary Q-products!
This page will serve as the Q-core women’s headquarters. It will be our central communication channel with you and we will share news, updates, and new research findings with you. Only Q-core women have access to this page and the privileged content we will share here.
Our progress this past year is strong! Here is the latest update:
We have developed a working health-tracking menstrual pad. The next step is to optimize it with you!
A SIMPLE SOLUTION FOR LOW RESOURCE AREAS
Our simple blood collection platform presents a groundbreaking opportunity to prevent deaths from cervical cancer and other reproductive ailments in low and middle income countries (LMICs). The problems with access to care in these regions are numerous. Safe and reliable blood collection is difficult and costly, transporting samples in a stable manner is unreliable, as is the collection of patient results and medical records. We partner with local care providers to distribute screening tests to women in rural areas of LMICs. Women easily self-administer the tests, and then receive follow up care from the local partners. Fully illiterate women in Zimbabwe were able to intuitively use the Q-pad, guided only by image illustrations.
HIGH-RISK HPV DETECTION & HIV VIRAL LOAD MEASUREMENT
We were able to detect high-risk HPV using only a Q-pad in rural Zimbabwe! Not only that, we were able to genotype the virus AND we detected MORE strains than the clinician-collected gold standard method! Our work on high- risk HPV in Zimbabwe has indicated that we may also be able to use Q-pads to measure viral loads in HIV infected women. A viral load test helps provide information on an infected person's health status including how well antiretroviral therapy (ART – treatment with HIV medicines) is controlling the virus. We are currently in the process of expanding our research protocol to explore this opportunity further in Zimbabwe!
TIGHTENING CONTROL FOR DIABETICS
Our pre-clinical study on HbA1c (average blood sugar) is well underway and showing that we can afford women the tightest control over their A1c with monthly readings obtained non-invasively during their period. Our FDA process is progressing well and according to plan. Our first launch will be the A1c Q-pad. By developing this Q-pad test, we are striving to improve quality of life for those living with diabetes. We also hope to target women at high-risk for developing diabetes as well as those who might be pre-diabetic. The goal is to empower women to make better lifestyle choices, enabling them to be accountable over their own health.